Correction: Increased proliferation and altered cell cycle regulation in pancreatic stem cells derived from patients with congenital hyperinsulinism
Authors:
Sophie G. Kellaway; Karolina Mosinska; Zainaba Mohamed; Alexander Ryan; Stephen Richardson; Melanie Newbould; Indraneel Banerjee; Mark J. Dunne; Karen E. Cosgrove
Published in the journal:
PLoS ONE 14(10)
Category:
Correction
doi:
https://doi.org/10.1371/journal.pone.0223999
The NC3Rs grant number is missing from the Funding statement. The correct Funding Statement is as follows: This work was funded by NC3Rs (https://www.nc3rs.org.uk/, SGK awarded to MJD, KC, NC/K500306/1), and Diabetes UK (https://www.diabetes.org.uk/, KM awarded to MJD, KC). AR was funded by Heptares/Innovate UK (https://soseiheptares.com/ awarded to MJD). KEC was funded by a Research Councils UK Academic Fellowship (https://www.ukri.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Zdroje
1. Kellaway SG, Mosinska K, Mohamed Z, Ryan A, Richardson S, Newbould M, et al. (2019) Increased proliferation and altered cell cycle regulation in pancreatic stem cells derived from patients with congenital hyperinsulinism. PLoS ONE 14(9): e0222350. https://doi.org/10.1371/journal.pone.0222350 31525223
Článok vyšiel v časopise
PLOS One
2019 Číslo 10
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
- Nejasný stín na plicích – kazuistika
- Těžké menstruační krvácení může značit poruchu krevní srážlivosti. Jaký management vyšetření a léčby je v takovém případě vhodný?
- Profylaxe infekční endokarditidy ve stomatologii
- Masturbační chování žen v ČR − dotazníková studie
Najčítanejšie v tomto čísle
- Correction: Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study
- Combining CDK4/6 inhibitors ribociclib and palbociclib with cytotoxic agents does not enhance cytotoxicity
- Efficacy of cotrimoxazole (Sulfamethoxazole-Trimethoprim) as a salvage therapy for the treatment of bone and joint infections (BJIs)
- Risk factors associated with IgA vasculitis with nephritis (Henoch–Schönlein purpura nephritis) progressing to unfavorable outcomes: A meta-analysis
Zvýšte si kvalifikáciu online z pohodlia domova
Všetky kurzy